+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Pharmacoeconomics and formulary decision making

Pharmacoeconomics and formulary decision making

Pharmacoeconomics 9(Suppl 1): 16-25

ISSN/ISBN: 1170-7690

PMID: 10160112

DOI: 10.2165/00019053-199600091-00005

Pharmacoeconomic assessment of formulary actions has become increasingly common in local, national, and international formulary decision making. Tactics for managing medication use include formulary management and drug policies. Pharmacoeconomic data can provide support for these formulary decisions. For example, pharmacoeconomic data can support the inclusion or exclusion of a drug on or from the formulary and support practice guidelines that promote the most cost-effective or appropriate utilisation of pharmaceutical products. Various strategies can be used to incorporate pharmacoeconomics into formulary decision making. These include using published pharmacoeconomic studies and economic modelling techniques, and conducting local pharmacoeconomic research. Criteria for evaluating the pharmacoeconomic literature, suggestions for employing economic models, and suggested guidelines for conducting pharmacoeconomic projects are discussed. Although most formularies are viewed as cost-containment tools, formularies should not be a list of the 'cheapest' alternatives. Today's formulary should contain agents that optimise therapeutic outcomes while controlling cost. Pharmacoeconomic assessments of formulary decisions help to ensure that the agents promoted by our formularies yield the highest outcome per dollar spent. A discussion of the process for formulary action in a US hospital, the influence of pharmacoeconomics on US formularies, and strategies for incorporating pharmacoeconomics into formulary decision making are presented in this paper.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 046964810

Download citation: RISBibTeXText

Related references

Pharmacoeconomics and the formulary decision-making process. Hospital Formulary 30(1): 42-50, 1995

Application of pharmacoeconomics to formulary decision making in managed care organizations. American Journal of Managed Care 8(2): 161-169, 2002

PMD13 Application of Pharmacoeconomics and Outcomes Research in Formulary Decision-Making. Value in Health 1(1): 76-76, 1998

The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal: Spj: the Official Publication of the Saudi Pharmaceutical Society 19(1): 51-56, 2011

A pharmacoeconomics and formulary management collaborative project to teach decision analysis principles. American Journal of Pharmaceutical Education 76(6): 115, 2012

Using pharmacoeconomics for policy making: is rational decision making enhanced by applying thresholds for cost-effectiveness?. Expert Review of Pharmacoeconomics and Outcomes Research 4(3): 247-250, 2004

Pharmacoeconomics--an aid to better decision-making. Journal of the European Academy of Dermatology and Venereology: Jeadv 19(Suppl): 34-39, 2005

Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers. Journal of Managed Care and Specialty Pharmacy 24(11): 1173-1183, 2018

Applying decision sciences to formulary decision-making. Pharmacoeconomics and Outcomes News 24(1): 3-4, 1995

Pharmacoeconomics in European decision-making. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 2(5): 319-322, 1999

Is there a role for pharmacoeconomics in decision making?. Pharmacoeconomics 30(10): 979; Author Reply 980, 2012

Pharmacoeconomics: NICE's approach to decision-making. British Journal of Clinical Pharmacology 70(3): 346-349, 2010

Growing role for pharmacoeconomics in R&D decision-making. Pharmacoeconomics and Outcomes News 189(1): 3-4, 1998

Decision analysis in formulary decision making. Pharmacoeconomics 3(6): 454-461, 1993

Pharmacoeconomics and the quality of decision-making by pharmacy and therapeutics committees. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 52(14 Suppl. 3): S24-S26, 1995